HEADER LECTIN 19-DEC-03 1UUH TITLE HYALURONAN BINDING DOMAIN OF HUMAN CD44 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CD44 ANTIGEN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HYALURONAN BINDING DOMAIN, RESIDUES 20-178; COMPND 5 SYNONYM: PHAGOCYTIC GLYCOPROTEIN I, PGP-1, HUTCH-I, EXTRACELLULAR COMPND 6 MATRIX RECEPTOR-III, ECMR-III, GP90 LYMPHOCYTE HOMING/ADHESION COMPND 7 RECEPTOR, HERMES ANTIGEN, HYALURONATE RECEPTOR, HEPARAN SULFATE COMPND 8 PROTEOGLYCAN, EPICAN, CDW44; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: FIRST RESIDUE IS IN FACT THE LAST RESIDUE OF THE COMPND 11 SIGNAL PEPTIDE, AND WOULD NORMALLY BE CLEAVED SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: DE3 PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET19B KEYWDS LECTIN, HYALURONAN, EXTRACELLULAR MATRIX, RECEPTOR, LINK-DOMAIN, C- KEYWDS 2 TYPE LECTIN, SUGAR-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR P.TERIETE,S.BANERJI,M.NOBLE,C.BLUNDELL,A.WRIGHT,A.PICKFORD,E.LOWE, AUTHOR 2 D.MAHONEY,M.TAMMI,J.KAHMANN,I.CAMPBELL,A.DAY,D.JACKSON REVDAT 4 06-NOV-24 1UUH 1 REMARK REVDAT 3 29-MAY-19 1UUH 1 REMARK LINK REVDAT 2 24-FEB-09 1UUH 1 VERSN REVDAT 1 04-MAR-04 1UUH 0 JRNL AUTH P.TERIETE,S.BANERJI,M.NOBLE,C.BLUNDELL,A.WRIGHT,A.PICKFORD, JRNL AUTH 2 E.LOWE,D.MAHONEY,M.TAMMI,J.KAHMANN,I.CAMPBELL,A.DAY, JRNL AUTH 3 D.JACKSON JRNL TITL STRUCTURE OF THE REGULATORY HYALURONAN-BINDING DOMAIN IN THE JRNL TITL 2 INFLAMMATORY LEUKOCYTE HOMING RECEPTOR CD44 JRNL REF MOL.CELL V. 13 483 2004 JRNL REFN ISSN 1097-2765 JRNL PMID 14992719 JRNL DOI 10.1016/S1097-2765(04)00080-2 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.9999 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 16553 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 881 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1200 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1900 REMARK 3 BIN FREE R VALUE SET COUNT : 52 REMARK 3 BIN FREE R VALUE : 0.2390 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2334 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 262 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.28000 REMARK 3 B22 (A**2) : 0.47000 REMARK 3 B33 (A**2) : -0.19000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.261 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.216 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.141 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.483 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.878 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2390 ; 0.020 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2068 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3258 ; 1.956 ; 1.937 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4818 ; 1.004 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 298 ; 8.415 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 366 ; 0.138 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2700 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 492 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 462 ; 0.240 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2531 ; 0.263 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 1416 ; 0.098 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 120 ; 0.216 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 14 ; 0.233 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 63 ; 0.273 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 15 ; 0.176 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1496 ; 0.982 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2436 ; 1.769 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 894 ; 2.854 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 822 ; 4.485 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL PLUS MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1UUH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-DEC-03. REMARK 100 THE DEPOSITION ID IS D_1290014252. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAY-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17476 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 23.310 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.820 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2989 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.53 REMARK 200 R MERGE FOR SHELL (I) : 0.18000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.160 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: SOLVE/RESOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING-DROP PROTEIN 13 MG/ML; WELL REMARK 280 BUFFER 12% PEG 3350, 50MM NACL, 10% GLYCEROL, PH 5.50, VAPOR REMARK 280 DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.44050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.83400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.63300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.83400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.44050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.63300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 170 REMARK 465 SER A 171 REMARK 465 ASN A 172 REMARK 465 PRO A 173 REMARK 465 THR A 174 REMARK 465 ASP A 175 REMARK 465 ASP A 176 REMARK 465 ASP A 177 REMARK 465 VAL A 178 REMARK 465 PRO B 170 REMARK 465 SER B 171 REMARK 465 ASN B 172 REMARK 465 PRO B 173 REMARK 465 THR B 174 REMARK 465 ASP B 175 REMARK 465 ASP B 176 REMARK 465 ASP B 177 REMARK 465 VAL B 178 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O SER A 112 O HOH A 2088 2.18 REMARK 500 O SER B 71 O HOH B 2064 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 70 CA - CB - CG ANGL. DEV. = 14.2 DEGREES REMARK 500 LEU B 70 CA - CB - CG ANGL. DEV. = 14.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 43 18.90 -152.26 REMARK 500 PRO A 125 30.18 -80.21 REMARK 500 TYR A 161 -15.99 -141.50 REMARK 500 SER B 43 12.55 -152.45 REMARK 500 SER B 112 -151.38 -103.37 REMARK 500 TYR B 114 -157.13 -138.13 REMARK 500 GLU B 126 -122.34 -117.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 HYALURONAN BINDING DOMAIN ONLY DBREF 1UUH A 20 178 UNP P16070 CD44_HUMAN 20 178 DBREF 1UUH B 20 178 UNP P16070 CD44_HUMAN 20 178 SEQRES 1 A 159 ALA GLN ILE ASP LEU ASN ILE THR CYS ARG PHE ALA GLY SEQRES 2 A 159 VAL PHE HIS VAL GLU LYS ASN GLY ARG TYR SER ILE SER SEQRES 3 A 159 ARG THR GLU ALA ALA ASP LEU CYS LYS ALA PHE ASN SER SEQRES 4 A 159 THR LEU PRO THR MSE ALA GLN MSE GLU LYS ALA LEU SER SEQRES 5 A 159 ILE GLY PHE GLU THR CYS ARG TYR GLY PHE ILE GLU GLY SEQRES 6 A 159 HIS VAL VAL ILE PRO ARG ILE HIS PRO ASN SER ILE CYS SEQRES 7 A 159 ALA ALA ASN ASN THR GLY VAL TYR ILE LEU THR SER ASN SEQRES 8 A 159 THR SER GLN TYR ASP THR TYR CYS PHE ASN ALA SER ALA SEQRES 9 A 159 PRO PRO GLU GLU ASP CYS THR SER VAL THR ASP LEU PRO SEQRES 10 A 159 ASN ALA PHE ASP GLY PRO ILE THR ILE THR ILE VAL ASN SEQRES 11 A 159 ARG ASP GLY THR ARG TYR VAL GLN LYS GLY GLU TYR ARG SEQRES 12 A 159 THR ASN PRO GLU ASP ILE TYR PRO SER ASN PRO THR ASP SEQRES 13 A 159 ASP ASP VAL SEQRES 1 B 159 ALA GLN ILE ASP LEU ASN ILE THR CYS ARG PHE ALA GLY SEQRES 2 B 159 VAL PHE HIS VAL GLU LYS ASN GLY ARG TYR SER ILE SER SEQRES 3 B 159 ARG THR GLU ALA ALA ASP LEU CYS LYS ALA PHE ASN SER SEQRES 4 B 159 THR LEU PRO THR MSE ALA GLN MSE GLU LYS ALA LEU SER SEQRES 5 B 159 ILE GLY PHE GLU THR CYS ARG TYR GLY PHE ILE GLU GLY SEQRES 6 B 159 HIS VAL VAL ILE PRO ARG ILE HIS PRO ASN SER ILE CYS SEQRES 7 B 159 ALA ALA ASN ASN THR GLY VAL TYR ILE LEU THR SER ASN SEQRES 8 B 159 THR SER GLN TYR ASP THR TYR CYS PHE ASN ALA SER ALA SEQRES 9 B 159 PRO PRO GLU GLU ASP CYS THR SER VAL THR ASP LEU PRO SEQRES 10 B 159 ASN ALA PHE ASP GLY PRO ILE THR ILE THR ILE VAL ASN SEQRES 11 B 159 ARG ASP GLY THR ARG TYR VAL GLN LYS GLY GLU TYR ARG SEQRES 12 B 159 THR ASN PRO GLU ASP ILE TYR PRO SER ASN PRO THR ASP SEQRES 13 B 159 ASP ASP VAL MODRES 1UUH MSE A 63 MET SELENOMETHIONINE MODRES 1UUH MSE A 66 MET SELENOMETHIONINE MODRES 1UUH MSE B 63 MET SELENOMETHIONINE MODRES 1UUH MSE B 66 MET SELENOMETHIONINE HET MSE A 63 8 HET MSE A 66 8 HET MSE B 63 8 HET MSE B 66 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 4(C5 H11 N O2 SE) FORMUL 3 HOH *262(H2 O) HELIX 1 1 SER A 45 PHE A 56 1 12 HELIX 2 2 THR A 62 SER A 71 1 10 HELIX 3 3 ALA A 98 ASN A 101 5 4 HELIX 4 4 ASN A 164 TYR A 169 1 6 HELIX 5 5 SER B 45 PHE B 56 1 12 HELIX 6 6 THR B 62 ILE B 72 1 11 HELIX 7 7 ALA B 98 ASN B 101 5 4 HELIX 8 8 ASN B 164 TYR B 169 1 6 SHEET 1 AA 8 GLY A 103 ILE A 106 0 SHEET 2 AA 8 HIS A 85 ARG A 90 -1 O ILE A 88 N TYR A 105 SHEET 3 AA 8 GLY A 80 ILE A 82 -1 O GLY A 80 N VAL A 87 SHEET 4 AA 8 ASP A 115 PHE A 119 1 O ASP A 115 N PHE A 81 SHEET 5 AA 8 VAL A 33 LYS A 38 -1 O PHE A 34 N CYS A 118 SHEET 6 AA 8 GLN A 21 ILE A 26 -1 O ASN A 25 N GLU A 37 SHEET 7 AA 8 PHE A 139 VAL A 148 1 O THR A 144 N ILE A 22 SHEET 8 AA 8 ARG A 154 GLU A 160 -1 O TYR A 155 N ILE A 147 SHEET 1 AB 2 ARG A 29 PHE A 30 0 SHEET 2 AB 2 GLU A 127 ASP A 128 -1 O ASP A 128 N ARG A 29 SHEET 1 BA 8 GLY B 103 ILE B 106 0 SHEET 2 BA 8 HIS B 85 ARG B 90 -1 O ILE B 88 N TYR B 105 SHEET 3 BA 8 GLY B 80 ILE B 82 -1 O GLY B 80 N VAL B 87 SHEET 4 BA 8 ASP B 115 PHE B 119 1 O ASP B 115 N PHE B 81 SHEET 5 BA 8 VAL B 33 LYS B 38 -1 O PHE B 34 N CYS B 118 SHEET 6 BA 8 GLN B 21 ILE B 26 -1 O ASN B 25 N GLU B 37 SHEET 7 BA 8 PHE B 139 VAL B 148 1 O THR B 144 N ILE B 22 SHEET 8 BA 8 ARG B 154 GLU B 160 -1 O TYR B 155 N ILE B 147 SHEET 1 BB 2 ARG B 29 PHE B 30 0 SHEET 2 BB 2 GLU B 127 ASP B 128 -1 O ASP B 128 N ARG B 29 SSBOND 1 CYS A 28 CYS A 129 1555 1555 2.05 SSBOND 2 CYS A 53 CYS A 118 1555 1555 2.06 SSBOND 3 CYS A 77 CYS A 97 1555 1555 2.04 SSBOND 4 CYS B 28 CYS B 129 1555 1555 2.07 SSBOND 5 CYS B 53 CYS B 118 1555 1555 2.07 SSBOND 6 CYS B 77 CYS B 97 1555 1555 2.05 LINK C THR A 62 N MSE A 63 1555 1555 1.33 LINK C MSE A 63 N ALA A 64 1555 1555 1.34 LINK C GLN A 65 N MSE A 66 1555 1555 1.33 LINK C MSE A 66 N GLU A 67 1555 1555 1.33 LINK C THR B 62 N MSE B 63 1555 1555 1.34 LINK C MSE B 63 N ALA B 64 1555 1555 1.34 LINK C GLN B 65 N MSE B 66 1555 1555 1.33 LINK C MSE B 66 N GLU B 67 1555 1555 1.33 CRYST1 48.881 77.266 87.668 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020458 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012942 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011407 0.00000 MTRIX1 1 -0.747460 -0.617720 -0.244390 -13.39000 1 MTRIX2 1 0.439440 -0.735660 0.515450 -13.60800 1 MTRIX3 1 0.498200 -0.277890 -0.821330 -23.46900 1